Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients

被引:62
作者
Chen, Chien-Hung
Chang, Ting-Tsung
Cheng, Ken-Sheng
Su, Wei-Wen
Yang, Sheng-Shun
Lin, Hans Hsienhong
Wu, Shun-Sheng
Lee, Chuan-Mo
Changchien, Chi-Sin
Chen, Chien-Jen
Sheu, Jin-Chuan
Chen, Ding-Shinn
Lu, Sheng-Nan [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[3] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan
[4] China Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Taichung, Taiwan
[5] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan
[6] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan
[7] Tzu Chi Gen Hosp, Dept Gastroenterol, Hualien, Taiwan
[8] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan
[9] Chang Gung Univ, Taoyuan, Taiwan
[10] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan
[11] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 10764, Taiwan
关键词
HBsAg; hepatocellular carcinoma; survival; Taiwan; young;
D O I
10.1111/j.1478-3231.2006.01309.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Our previous study showed that male hepatocellular carcinoma (HCC) patients below 40 years of age had the worst survival in the initial several years, but had the best prognosis thereafter. Thus, it seems that age has a paradoxical influence on the prognosis. To further clarify the issue of age on HCC prognosis, we initiated this study. Methods: A total of 11 312 HCC cases from seven medical centers from 1986 to 2002 were included. We analyzed the 1-year survival and survival after 1 year. Results: Male gender, age younger than 40 years old and hepatitis B virus (HBV) were associated with worse 1-year survival. In contrast, male gender, age younger than 40 years old and HBV were associated with better survival after 1 year. Higher percentage of the young HCC patients had a tumor size larger than 3 cm. 83.7% of HCC patients below 40 years of age were male and 89.8% of them were HBV carriers. Conclusions: If we encountered a young HCC patient, the patient will probably be a male HBV carrier. He would probably have larger tumor and is more likely to expire within 1 year than the older HCC patients. However, if the young HCC patient can survive for more than 1 year, he would probably have better survival in the following years than the older patients.
引用
收藏
页码:766 / 773
页数:8
相关论文
共 35 条
  • [1] [Anonymous], J FORMOS MED ASS
  • [2] Aramaki M, 2005, HEPATO-GASTROENTEROL, V52, P1795
  • [3] Management of hepatoceullular carcinoma
    Bruix, J
    Sherman, M
    [J]. HEPATOLOGY, 2005, 42 (05) : 1208 - 1236
  • [4] Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
    Chang, MH
    Chen, CJ
    Lai, MS
    Hsu, HM
    Wu, TC
    Kong, MS
    Liang, DC
    Shau, WY
    Chen, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) : 1855 - 1859
  • [5] Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma
    Chen, CH
    Huang, GT
    Lee, HS
    Yang, PM
    Chen, DS
    Sheu, JC
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 27 (03) : 236 - 239
  • [6] CHEN CH, IN PRESS J GASTROENT
  • [7] Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    Chen, CJ
    Yang, HI
    Su, J
    Jen, CL
    You, SL
    Lu, SN
    Huang, GT
    Iloeje, UH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01): : 65 - 73
  • [8] CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597
  • [9] Ebara M, 1998, HEPATO-GASTROENTEROL, V45, P1214
  • [10] FURUTA T, 1990, CANCER-AM CANCER SOC, V66, P2395, DOI 10.1002/1097-0142(19901201)66:11<2395::AID-CNCR2820661125>3.0.CO